KR890002204B1 - 퍼플로로탄소 유제, 그의 제법 및 그 유제를 포함하는 수성 약제 조성물 - Google Patents

퍼플로로탄소 유제, 그의 제법 및 그 유제를 포함하는 수성 약제 조성물 Download PDF

Info

Publication number
KR890002204B1
KR890002204B1 KR1019830003805A KR830003805A KR890002204B1 KR 890002204 B1 KR890002204 B1 KR 890002204B1 KR 1019830003805 A KR1019830003805 A KR 1019830003805A KR 830003805 A KR830003805 A KR 830003805A KR 890002204 B1 KR890002204 B1 KR 890002204B1
Authority
KR
South Korea
Prior art keywords
emulsion
oxygen
dispersion
pharmaceutical composition
pfc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830003805A
Other languages
English (en)
Korean (ko)
Other versions
KR840005660A (ko
Inventor
엠 유하스 죤
엘 군맨 로버어트
이이 무어 로버어트
Original Assignee
애더맨테크 인코포레이팃드
마아커스 다불류 하젠타인 쥬니어
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR890002204(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 애더맨테크 인코포레이팃드, 마아커스 다불류 하젠타인 쥬니어 filed Critical 애더맨테크 인코포레이팃드
Publication of KR840005660A publication Critical patent/KR840005660A/ko
Application granted granted Critical
Publication of KR890002204B1 publication Critical patent/KR890002204B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019830003805A 1982-08-17 1983-08-16 퍼플로로탄소 유제, 그의 제법 및 그 유제를 포함하는 수성 약제 조성물 Expired KR890002204B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40858982A 1982-08-17 1982-08-17
US408.589 1982-08-17
US51715083A 1983-07-25 1983-07-25
US517.150 1983-07-25
US408589 1989-09-18

Publications (2)

Publication Number Publication Date
KR840005660A KR840005660A (ko) 1984-11-15
KR890002204B1 true KR890002204B1 (ko) 1989-06-23

Family

ID=27020315

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830003805A Expired KR890002204B1 (ko) 1982-08-17 1983-08-16 퍼플로로탄소 유제, 그의 제법 및 그 유제를 포함하는 수성 약제 조성물

Country Status (19)

Country Link
EP (1) EP0105584B1 (https=)
JP (1) JPS59501665A (https=)
KR (1) KR890002204B1 (https=)
AU (1) AU559559B2 (https=)
CA (1) CA1225027A (https=)
CH (1) CH665952A5 (https=)
DE (2) DE3378954D1 (https=)
ES (1) ES8502405A1 (https=)
FI (1) FI841513A0 (https=)
GB (1) GB2134787A (https=)
GR (1) GR79383B (https=)
IE (1) IE55618B1 (https=)
IL (1) IL69505A (https=)
NL (1) NL8320264A (https=)
NO (1) NO841519L (https=)
PH (2) PH25492A (https=)
PT (1) PT77204B (https=)
SE (1) SE8402098L (https=)
WO (1) WO1984000686A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
CA1257828A (en) * 1984-04-16 1989-07-25 William Mccormick Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
WO1991003267A1 (en) * 1989-08-28 1991-03-21 Sekins K Michael Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
WO1993018748A1 (en) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
AU4645099A (en) 1998-07-09 2000-02-01 Yoram Harth Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
US20040122492A1 (en) 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
GB0200721D0 (en) * 2002-01-14 2002-02-27 Univ Bristol Toxicity test
RU2440158C2 (ru) * 2010-02-25 2012-01-20 Юрий Александрович Белый Способ фотодинамической терапии субъектов, страдающих злокачественными опухолями
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc FLUORCHEMICAL ANTIFIBROBLAST EMULSION THERAPIES

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828085A (en) * 1970-07-09 1974-08-06 Allied Chem Novel amidoamine oxides
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US4041086A (en) * 1972-02-07 1977-08-09 Sun Ventures, Inc. Process of manufacture of flourinated alkyladamantanes
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (https=) * 1973-10-05 1978-09-01
DE2524363A1 (de) * 1975-06-02 1976-12-16 Boehringer Sohn Ingelheim Neue pharmazeutische mittel
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
JPS5331209A (en) * 1976-09-03 1978-03-24 Hitachi Ltd Small compressor cylinder for refrigerating machine and production of same
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
JPS6033367B2 (ja) * 1978-11-24 1985-08-02 株式会社ミドリ十字 酸素運搬輸液
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
GB2070429B (en) * 1979-06-25 1984-05-02 Suntech Use of perfluorocarbon as burn treatment
CA1181011A (en) * 1980-05-27 1985-01-15 Robert P. Geyer Perfluorinated n,n-dimethyl cyclohexylmethylamine and emulsions containing the same
GR78151B (https=) * 1982-04-05 1984-09-26 Alcon Lab Inc

Also Published As

Publication number Publication date
DE3378954D1 (en) 1989-02-23
ES524972A0 (es) 1985-01-01
PH25027A (en) 1991-01-28
GR79383B (https=) 1984-10-22
PH25492A (en) 1991-07-24
IE55618B1 (en) 1990-11-21
PT77204B (en) 1986-02-04
EP0105584A1 (en) 1984-04-18
FI841513A7 (fi) 1984-04-16
FI841513L (fi) 1984-04-16
GB2134787A (en) 1984-08-22
ES8502405A1 (es) 1985-01-01
PT77204A (en) 1983-09-01
IL69505A (en) 1990-03-19
JPS59501665A (ja) 1984-10-04
FI841513A0 (fi) 1984-04-16
SE8402098D0 (sv) 1984-04-16
IE831925L (en) 1984-02-17
AU559559B2 (en) 1987-03-12
CH665952A5 (de) 1988-06-30
NO841519L (no) 1984-04-16
IL69505A0 (en) 1983-11-30
EP0105584B1 (en) 1989-01-18
WO1984000686A1 (en) 1984-03-01
CA1225027A (en) 1987-08-04
DE3390172T1 (de) 1984-11-29
KR840005660A (ko) 1984-11-15
NL8320264A (nl) 1984-07-02
SE8402098L (sv) 1984-04-16
AU1941383A (en) 1984-03-07

Similar Documents

Publication Publication Date Title
KR890002204B1 (ko) 퍼플로로탄소 유제, 그의 제법 및 그 유제를 포함하는 수성 약제 조성물
EP0625068B1 (en) Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them
US5077036A (en) Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
US3911138A (en) Artificial blood and method for supporting oxygen transport in animals
Suit et al. Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/Sed mouse to radiation
US4889525A (en) Sensitization of hypoxic tumor cells and control of growth thereof
US4742050A (en) Sensitization of hypoxic tumor cells and control of growth thereof
USRE35748E (en) Treatments employing drug containing matrices for introduction into cellular lesion areas
GB2041221A (en) X-ray contrast compositions
US5300528A (en) Use of perfluoroethyldimethyl cyclohexane for oxygen transport
Lane Perfluorochemical-based artificial oxygen carrying red cell substitutes
KISHIMOTO et al. Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-groing rat hepatic tumor after intra-hepatic arterial administration
Cay et al. Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin.
US20050222116A1 (en) Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
Guichard The use of fluorocarbon emulsions in cancer radiotherapy
CA2453993A1 (en) Method and composition for treatment of cancer
Lowe Properties and biomedical applications of perfluorochemicals and their emulsions
MacManus et al. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice
Klubes et al. Attempts to increase intratumoral blood flow in the rat solid Walker 256 tumor by the use of the perfluorocarbon emulsion Fluosol-DA
PH26149A (en) Perfluorocarbon emulsions and their preparation
TWI248366B (en) Pharmaceutical composition containing radioiodine-labeled 5-iodo-2'-deoxyuridine and preparation thereof for remaining in hepatoma
Harris et al. Sensitization of anoxic mouse tumours to X-rays with diamide and nifuroxime
Rockwell et al. Effects of the perfluorochemical emulsion FMIQ on the radiation response of EMT6 tumours
Vagianos et al. Increased uptake of 5-FU in experimental liver tumours by simultnaeous infusion of norepinephrine
BENGMARK Increased Uptake of 5-FU in Experimental Liver Tumours by Simultaneous Infusion of Norepinephrine

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19920624

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19920624